Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma
Original Article
D.F. Bajorin, J.A. Witjes, J.E. Gschwend, M. Schenker, B.P. Valderrama, Y. Tomita, A. Bamias, T. Lebret, S.F. Shariat, S.H. Park, D. Ye, M. Agerbaek, D. Enting, R. McDermott, P. Gajate, A. Peer, M.I. Milowsky, A. Nosov, J.N.A. Jr., Jr., K. Tupikowski, L. Toms, B.S. Fischer, A. Qureshi, S. Collette, K. Unsal-Kacmaz, E. Broughton, D. Zardavas, H.B. Koon, and M.D. Galsky
N Engl J Med 2021;384:2102-2114
Course summary
Available credit:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course opens:
06/02/2021
Course expires:
06/03/2023
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Saturday, June 3, 2023 - 11:59pm.

Facebook
X
LinkedIn
Forward